Federico Cerrone is assistant professor in Bioprocess Engineering at Dublin City University School of Biotechnology ...
New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating ...
Image in Creative Commons. In 1967, Hungarian scientist Endre Mester tried to cure skin cancer in mice using a low-powered ruby laser. He failed to stop ...
Robbins LLP is Investigating Allegations that Nektar Therapeutics (NKTR) Overstated the Prospects of its REZOLVE-AA Trial According to the complaint, during the class period, defendants failed to ...
Add Yahoo as a preferred source to see more of our stories on Google. Texas A&M study shows cherry compounds may slow aggressive breast cancer TYLER, Texas (KETK) — Researchers at Texas A&M University ...
An atmospheric river that moved into Oregon on Wednesday is expected to pelt the Portland area with about 4 inches of rain through early Saturday. The Coast Range will see even more rain, with the ...
Capricor Therapeutics’ deramiocel was rejected in July 2025, potentially caught between Nicole Verdun, a former top biologics regulator at the FDA, and Vinay Prasad, director of the Center for ...
18hon MSN
Fat cells burn energy to make heat – making them the next frontier of weight loss therapies
Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...
Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...
Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can "educate" the immune system to find and destroy disease-causing cells throughout ...
MedPage Today on MSN
Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis
Clinical worsening also occurred less frequently with treprostinil ...
Researchers identify PV neurons in the prefrontal cortex as the gatekeepers of drug addiction relapse, offering a new target for precision treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results